Immix Biopharma, Inc. IMMX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s net change in cash?
- Immix Biopharma, Inc. (IMMX) reported net change in cash of -$14.68M in Q1 2026.
- How has Immix Biopharma, Inc.'s net change in cash changed year-over-year?
- Immix Biopharma, Inc.'s net change in cash decreased by 733.6% year-over-year, from -$1.76M to -$14.68M.
- What is the long-term trend for Immix Biopharma, Inc.'s net change in cash?
- Over 2 years (2021 to 2025), Immix Biopharma, Inc.'s net change in cash has grown at a 110.2% compound annual growth rate (CAGR), from $17.25M to $76.25M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.